Bausch + Lomb Review on B Vitamins and Age-Related Macular Degeneration
Bausch + Lomb Corporation announced the publication of a narrative review in Ophthalmology and Therapy, exploring the role of specific B vitamins in potentially reducing the risk and progression of age-related macular degeneration (AMD), a significant cause of vision loss in individuals aged 50 and older. This review is based on over two decades of scientific research.
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Ophthalmology and Therapy published a narrative review highlighting the role of certain B vitamins in reducing the risk of development and progression of AMD1, a leading cause of vision loss in Americans 50 years of age or older.2 Drawing on more than two decades of scientific research, the publication synt